Is Vaxart Inc (vxrt) a good stock to buy?
Apr 14, 2022 · VXRT Vaxart Inc — Stock Price and Discussion | Stocktwits. Vaxart Inc NASDAQ Updated Apr 14, 2022 11:59 PM. VXRT 4.66 0.22 (4.51%) Post-Market 0.00 (0.00%) 76,017. Key Data. 52wk Low 3.91. 52wk High 11.11.
What does vxrt stand for?
Shares of biotech Vaxart (NASDAQ: VXRT) soared back in 2020 following enthusiasm that the company would eventually become a leader in the COVID-19 vaccine market. Vaxart has yet to …
How often are the vxrt stock predictions updated?
Mar 27, 2022 · Vaxart's stock was trading at $2.07 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, VXRT shares have increased by 134.3% and is now trading at $4.85. View which stocks have been most impacted by COVID-19.
Is vxrt a sell or buy on Robinhood?
Real time Vaxart, Inc (VXRT) stock price quote, stock graph, news & analysis.
Is VXRT a buy or sell?
Out of 4 analysts, 3 (75%) are recommending VXRT as a Strong Buy, 0 (0%) are recommending VXRT as a Buy, 1 (25%) are recommending VXRT as a Hold, 0 (0%) are recommending VXRT as a Sell, and 0 (0%) are recommending VXRT as a Strong Sell. What is VXRT's earnings growth forecast for 2022-2024?
Who owns VXRT stock?
Top 10 Owners of Vaxart IncStockholderStakeShares ownedSSgA Funds Management, Inc.10.39%13,072,021BlackRock Fund Advisors6.13%7,709,060The Vanguard Group, Inc.4.51%5,668,354D. E. Shaw & Co. LP1.69%2,126,9246 more rows
What is the forecast for VXRT stock?
Stock Price Forecast The 4 analysts offering 12-month price forecasts for Vaxart Inc have a median target of 11.50, with a high estimate of 18.00 and a low estimate of 7.00. The median estimate represents a +182.90% increase from the last price of 4.07.
How do I buy vaxart stock?
How to buy shares in VaxartCompare share trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. Complete an application with your details.Confirm your payment details. Fund your account.Research the stock. ... Purchase now or later. ... Check in on your investment.
Why is vaxart dropping?
The biotech's stock has been sliding hard over the past month and half for two related reasons: Vaxart's oral COVID-19 vaccine pill may not be on the market until the pandemic is starting to fade from the daily news cycle.Oct 7, 2021
How many shares does vaxart have?
Share StatisticsAvg Vol (3 month) 32.86MShares Outstanding 5125.5MImplied Shares Outstanding 6N/AFloat 8124.61M% Held by Insiders 10.71%7 more rows
Will vaxart go up tomorrow?
NEWS for Vaxart, Inc....Munafa value: 40 as on 08 Fri Apr 2022.Downside target4.5Upside target4.79Upside target4.87Upside target4.88Upside target5.045 more rows
Will Ocugen go up?
Long-term Ocugen stock forecast 2022-2025 The site predicted that the share price could climb over the next year, to $7.2 by March 2023.
Is OCGN a buy?
The consensus among Wall Street equities research analysts is that investors should "hold" Ocugen stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OCGN, but not buy additional shares or sell existing shares.
What does vaxart Inc do?
Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery system.
Is Vaxart a buy right now?
4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Vaxart in the last year. There are currently 1 hold rati...
How has Vaxart's stock price been impacted by COVID-19?
Vaxart's stock was trading at $2.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since the...
When is Vaxart's next earnings date?
Vaxart is scheduled to release its next quarterly earnings announcement on Monday, May 2nd 2022. View our earnings forecast for Vaxart .
How were Vaxart's earnings last quarter?
Vaxart, Inc. (NASDAQ:VXRT) issued its quarterly earnings data on Thursday, February, 24th. The biotechnology company reported ($0.17) earnings per...
When did Vaxart's stock split? How did Vaxart's stock split work?
Vaxart shares reverse split on the morning of Wednesday, February 14th 2018. The 1-11 reverse split was announced on Tuesday, February 13th 2018. T...
What price target have analysts set for VXRT?
4 brokerages have issued 12-month price targets for Vaxart's shares. Their forecasts range from $9.00 to $18.00. On average, they expect Vaxart's s...
Who are Vaxart's key executives?
Vaxart's management team includes the following people: Andrei Floroiu , President CEO, CFO & Director Sean N. Tucker , Chief Scientific Officer...
Who are some of Vaxart's key competitors?
Some companies that are related to Vaxart include ImmunityBio (IBRX) , Twist Bioscience (TWST) , Bavarian Nordic A/S (BVNRY) , Iovance Biothera...
What other stocks do shareholders of Vaxart own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Vaxart investors own include Inovio Pharmaceuticals (INO)...
Longshot Covid Play Vaxart Stock Is Too Risky at These Prices
Vaxart, Inc.'s (NASDAQ:VXRT) Shift From Loss To Profit
When I first wrote about Vaxart (NASDAQ:VXRT) stock on Aug. 10, I was completely enamored by the clinical-stage biotech company’s attempts to bring an oral Covid-19 vaccine to the market.
Vaxart Announces Highly Regarded Biotech Executive Julie M. Cherrington, Ph.D., Joins Board of Directors
Vaxart, Inc. ( NASDAQ:VXRT ) is possibly approaching a major achievement in its business, so we would like to shine...
Vaxart Announces Creation of New Scientific and Clinical Advisory Board
Vaxart, Inc. (NASDAQ: VXRT) today announced the addition of Julie M. Cherrington, Ph.D., to the company's board of directors. Dr. Cherrington is an experienced life science executive with extensive insights into taking drugs through the development process to commercialization.
Is the Options Market Predicting a Spike in Vaxart (VXRT) Stock?
Vaxart, Inc. (NASDAQ: VXRT), today announced the creation of an eight-member Scientific and Clinical Advisory Board.
Why Shares of Vaxart Are Soaring Today
Investors need to pay close attention to Vaxart (VXRT) stock based on the movements in the options market lately.
VAXART, INC. (VXRT) Reports Q2 Loss, Misses Revenue Estimates
Shares of clinical-stage vaccine developer Vaxart (NASDAQ: VXRT) are up again today, gaining 12.34% to $9.83 apiece as of 2:30 p.m. EDT. The stock is up 21% over the past five trading days due to greater capital inflows after the company released encouraging second-quarter earnings on Aug. 5.
Is Vaxart a buy right now?
VAXART, INC. (VXRT) delivered earnings and revenue surprises of 7.14% and -79.64%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
What stocks does MarketBeat like better than Vaxart?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vaxart in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Vaxart stock.#N#View analyst ratings for Vaxart or view top-rated stocks.
Are investors shorting Vaxart?
Wall Street analysts have given Vaxart a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Vaxart wasn't one of them.
When is Vaxart's next earnings date?
Vaxart saw a decline in short interest during the month of July. As of July 30th, there was short interest totaling 21,330,000 shares, a decline of 14.2% from the July 15th total of 24,860,000 shares. Based on an average daily volume of 10,300,000 shares, the days-to-cover ratio is presently 2.1 days.#N#View Vaxart's Short Interest.
How were Vaxart's earnings last quarter?
Vaxart is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.#N#View our earnings forecast for Vaxart.
How has Vaxart's stock been impacted by COVID-19 (Coronavirus)?
Vaxart, Inc. (NASDAQ:VXRT) announced its quarterly earnings results on Thursday, August, 5th. The biotechnology company reported ($0.13) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.14) by $0.01.
When did Vaxart's stock split? How did Vaxart's stock split work?
Vaxart's stock was trading at $2.07 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, VXRT stock has increased by 323.2% and is now trading at $8.76.#N#View which stocks have been most impacted by COVID-19.
Recently Viewed Tickers
Vaxart shares reverse split before market open on Wednesday, February 14th 2018. The 1-11 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 13th 2018.
Vaxart Inc
Visit a quote page and your recently viewed tickers will be displayed here.
Signals & Forecast
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.
Support, Risk & Stop-loss
The Vaxart stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock.
Is Vaxart stock A Buy?
Vaxart finds support from accumulated volume at $8.74 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
VXRT Target Price
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Vaxart stock to perform well in the short-term.
Vaxart Inc ( VXRT ) Stock Market info
VXRT price target in 14 days: 9.604 USD* upside and 8.364 USD* downside. (Highest and lowest possible predicted price in a 14 day period)
Vaxart Inc ( VXRT ) Stock Price Prediction, Stock Forecast for next months and years
Recommendations: Buy or sell Vaxart stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Vaxart share forecasts, stock quote and buy / sell signals below. According to present data Vaxart's VXRT shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).